View Notice

National - Consultancy to Cost the National AIDS Commission’s HIV & TB Strategic and M&E Plans.
Procurement Process :RFP - Request for proposal
Office :UNDP Country Office - BELIZE
Deadline :28-Sep-17
Posted on :14-Sep-17
Development Area :CONSULTANTS  CONSULTANTS
Reference Number :40913
Link to Atlas Project :
00081526 - Support to Belize HIV and TB national response-GF
Documents :
TOR-Costing Strategic and ME Plan
Template for Confirmation of Interest and Submission
Individual Contract Template
UNDP General Terms and Conditions for IC
Overview :

The National AIDS Commission, the multi-sectorial group of entities working to halt and prevent the spread of HIV and TB in Belize as the National Response, is at a crucial juncture in its existence. It is readying itself for a comprehensive transition readiness exercise while beginning to prepare for a possible final grant from the Global Fund to fight the two diseases in Belize. As such, one of the most significant tools to inform these processes is the costing of the national strategic and M&E plans.

With a country facing 90% debt against its GDP and 55 % of its population below 25 years, within a context of almost 3,000 persons living with HIV and 120 persons living with TB, this an exercise that will provide the basis for the implementation and quality of service to the National Response. By being able to create systematic reports on the financial resources required for TB and HIV management and control as well as on sources of funding and funding gaps, the National Response will be better able to assess its financial needs and resource allocation strategies to better achieve its goals. The management of TB and HIV necessitates a united response; and therefore, costed national Strategic and M&E Plans will inform the investment opportunities and gaps for better and more sustainable planning.

The purpose of the consultancy is to provide technical assistance to design techniques, structures and processes that will improve the financial knowledge of the relevant authorities about diseases-related financial projections, investment budgets and financial performance of the TB- and HIV-disease response programmes.